89bio Inc Stock Fundamentals

ETNB Stock  USD 8.38  0.40  5.01%   
89bio Inc fundamentals help investors to digest information that contributes to 89bio's financial success or failures. It also enables traders to predict the movement of 89bio Stock. The fundamental analysis module provides a way to measure 89bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 89bio stock.
At present, 89bio's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.9 M, whereas Tax Provision is forecasted to decline to 10,000.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

89bio Inc Company Shares Outstanding Analysis

89bio's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current 89bio Shares Outstanding

    
  117.58 M  
Most of 89bio's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 89bio Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

89bio Shares Outstanding Historical Pattern

Today, most investors in 89bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 89bio's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of 89bio shares outstanding as a starting point in their analysis.
   89bio Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

89bio Common Stock Shares Outstanding

Common Stock Shares Outstanding

74.73 Million

At present, 89bio's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, 89bio Inc has 117.58 M of shares currently outstending. This is 34.87% lower than that of the Biotechnology sector and 10.04% higher than that of the Health Care industry. The shares outstanding for all United States stocks is 79.44% higher than that of the company.

89bio Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining 89bio's current stock value. Our valuation model uses many indicators to compare 89bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 89bio competition to find correlations between indicators driving 89bio's intrinsic value. More Info.
89bio Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, 89bio's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 89bio's earnings, one of the primary drivers of an investment's value.

89bio Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 89bio's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics of similar companies.
89bio is currently under evaluation in shares outstanding category among its peers.

89bio Current Valuation Drivers

We derive many important indicators used in calculating different scores of 89bio from analyzing 89bio's financial statements. These drivers represent accounts that assess 89bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of 89bio's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap279.7M392.1M262.7M443.1M398.8M235.7M
Enterprise Value186.3M187.4M131.3M407.9M367.1M385.4M

89bio ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 89bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 89bio's managers, analysts, and investors.
Environmental
Governance
Social

89bio Fundamentals

About 89bio Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 89bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue273 K147.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:
Check out 89bio Piotroski F Score and 89bio Altman Z Score analysis.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.96)
Return On Assets
(0.41)
Return On Equity
(0.73)
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.